首页> 美国政府科技报告 >Construction of Synthetic Immunogens in View of Developing Orally-Active Anti-Enterotoxigenic E. coli Vaccines.
【24h】

Construction of Synthetic Immunogens in View of Developing Orally-Active Anti-Enterotoxigenic E. coli Vaccines.

机译:从开发口服活性抗肠毒素大肠杆菌疫苗的角度构建合成免疫原。

获取原文

摘要

The aim of this research was to build immunogens susceptible of inducing a response against enterotoxigenic E. coli (Escherichia coli) (ETEC) following oral administration. The antigenic determinants were peptides copying structures of the colonization factor antigens (CFA), the carriers were either the Beta-chain of cholera toxin or a synthetic copy of one of its fragment. This fragment is known to bind in the Payer's patches the GM1 ganglioside which represents the toxin receptor. Two different E. coli peptides have been analyzed by HPLC (high performance liquid chromatography). Eight different conjugates have been prepared using glutaraldehyde or carbodiimide. The two peptides have been linked to muramyl dipeptide-Lys, 6-0-succinyl murabutide, Beta-chain of cholera toxin and the GM1 ganglioside binding peptide. After analysis, these conjugates have been sent to Dr. Reid to be tested in in vitro systems. They have been administered to mice orally. The antibody response has been studied in sera. Only a slight anti-Beta-cholera toxin response has been obtained. It would be advisable to increase the dosage of immunogens. Keywords: 1-Orally-active vaccines, 2-Synthetic enterotoxigenic E. coli immunogens, 3-Muramyl dipeptides, 4-Synthetic cholera toxin receptor, 5-GM1 ganglioside, RA 1. (jg)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号